The controversial move affects development of vaccines against COVID-19, flu and H5N1, drawing criticism from public health ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

The US Department of Health and Human Services (HHS) plans to cancel $500m (£376m) in funding for mRNA vaccines being ...

Health and Human Services Secretary Robert F. Kennedy Jr. has canceled $500 million in vaccine development after “listening ...

President Donald Trump's administration on Tuesday announced it would terminate 22 federal contracts for mRNA-based vaccines, ...

That kind of shot was first used during the Covid-19 pandemic, but the health secretary has been sharply critical of the ...

Pfizer Q2 2025 earnings show 10% revenue growth, raised EPS guidance, strong R&D, and operational execution. Explore growth drivers and policy risks.

In the second quarter, Pfizer reported adjusted diluted earnings per share of $0.78 on revenue of nearly $14.7 billion. Both ...

Pfizer said its full-year profit should benefit from cost cuts across its research and manufacturing operations after posting ...

Pfizer beats Q2 2025 estimates, raises EPS guidance, boasts a 7%+ dividend yield, yet faces patent and pricing risks. See why ...